CLPTClearPoint Neuro, Inc.
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. Th…
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
 ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript Revenue grew 18% to $10.9 million as neurosurgery navigation surged 62%. | ||
 ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary Moby summary of ClearPoint Neuro, Inc.'s Q2 2026 earnings call | ||
 ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say The headline numbers for ClearPoint Neuro (CLPT) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. | ||
 ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -31.03% and -16.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 ClearPoint Neuro Q2 Earnings Call Highlights ClearPoint Neuro (NASDAQ:CLPT) reported second-quarter 2026 revenue growth while outlining a shift in investment priorities toward clinical capacity, preclinical laboratory services and technologies intended to support commercial-scale neuro drug delivery. Total revenue for the three months ended J | ||
 Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | ||
 OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates OPKO Health (OPK) delivered earnings and revenue surprises of +87.50% and +24.68%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 DarioHealth (DRIO) Moves 12.9% Higher: Will This Strength Last? DarioHealth (DRIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. | ||